Ovid Therapeutics
OVID
OVID
64 hedge funds and large institutions have $163M invested in Ovid Therapeutics in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 18 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
10% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 20
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Holders
64
Holding in Top 10
2
Calls
$107K
Puts
–
Top Buyers
| 1 | +$6.01M | |
| 2 | +$1.31M | |
| 3 | +$431K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$317K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$258K |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$369K | |
| 3 | -$305K | |
| 4 |
DA
DCF Advisers
Greenwich,
Connecticut
|
-$132K |
| 5 |
Renaissance Technologies
New York
|
-$130K |